343 related articles for article (PubMed ID: 26805787)
1. Recent advances in co-amorphous drug formulations.
Dengale SJ; Grohganz H; Rades T; Löbmann K
Adv Drug Deliv Rev; 2016 May; 100():116-25. PubMed ID: 26805787
[TBL] [Abstract][Full Text] [Related]
2. Dissolution properties of co-amorphous drug-amino acid formulations in buffer and biorelevant media.
Heikkinen AT; DeClerck L; Löbmann K; Grohganz H; Rades T; Laitinen R
Pharmazie; 2015 Jul; 70(7):452-7. PubMed ID: 26373205
[TBL] [Abstract][Full Text] [Related]
3. Insights into co-amorphous systems in therapeutic drug delivery.
Singh R; Joshi V; Mehetre N; Sangamwar AT
Ther Deliv; 2021 Mar; 12(3):245-265. PubMed ID: 33745286
[TBL] [Abstract][Full Text] [Related]
4. Supersaturating drug delivery systems: The potential of co-amorphous drug formulations.
Laitinen R; Löbmann K; Grohganz H; Priemel P; Strachan CJ; Rades T
Int J Pharm; 2017 Oct; 532(1):1-12. PubMed ID: 28870764
[TBL] [Abstract][Full Text] [Related]
5. Co-amorphous systems for the delivery of poorly water-soluble drugs: recent advances and an update.
Han J; Wei Y; Lu Y; Wang R; Zhang J; Gao Y; Qian S
Expert Opin Drug Deliv; 2020 Oct; 17(10):1411-1435. PubMed ID: 32683996
[TBL] [Abstract][Full Text] [Related]
6. Amino acids as co-amorphous stabilizers for poorly water soluble drugs--Part 1: preparation, stability and dissolution enhancement.
Löbmann K; Grohganz H; Laitinen R; Strachan C; Rades T
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):873-81. PubMed ID: 23537574
[TBL] [Abstract][Full Text] [Related]
7. Recent Advances in Enhancement of Dissolution and Supersaturation of Poorly Water-Soluble Drug in Amorphous Pharmaceutical Solids: A Review.
Shi Q; Li F; Yeh S; Moinuddin SM; Xin J; Xu J; Chen H; Ling B
AAPS PharmSciTech; 2021 Dec; 23(1):16. PubMed ID: 34893936
[TBL] [Abstract][Full Text] [Related]
8. Emerging trends in the stabilization of amorphous drugs.
Laitinen R; Löbmann K; Strachan CJ; Grohganz H; Rades T
Int J Pharm; 2013 Aug; 453(1):65-79. PubMed ID: 22569230
[TBL] [Abstract][Full Text] [Related]
9. Solid dispersions, part I: recent evolutions and future opportunities in manufacturing methods for dissolution rate enhancement of poorly water-soluble drugs.
Bikiaris DN
Expert Opin Drug Deliv; 2011 Nov; 8(11):1501-19. PubMed ID: 21919807
[TBL] [Abstract][Full Text] [Related]
10. Permeability of glibenclamide through a PAMPA membrane: The effect of co-amorphization.
Ruponen M; Visti M; Ojarinta R; Laitinen R
Eur J Pharm Biopharm; 2018 Aug; 129():247-256. PubMed ID: 29894814
[TBL] [Abstract][Full Text] [Related]
11. Application of melt extrusion in the development of a physically and chemically stable high-energy amorphous solid dispersion of a poorly water-soluble drug.
Lakshman JP; Cao Y; Kowalski J; Serajuddin AT
Mol Pharm; 2008; 5(6):994-1002. PubMed ID: 19434852
[TBL] [Abstract][Full Text] [Related]
12. Melt extrusion with poorly soluble drugs.
Shah S; Maddineni S; Lu J; Repka MA
Int J Pharm; 2013 Aug; 453(1):233-52. PubMed ID: 23178213
[TBL] [Abstract][Full Text] [Related]
13. Impact of polymer type on bioperformance and physical stability of hot melt extruded formulations of a poorly water soluble drug.
Mitra A; Li L; Marsac P; Marks B; Liu Z; Brown C
Int J Pharm; 2016 May; 505(1-2):107-14. PubMed ID: 27012984
[TBL] [Abstract][Full Text] [Related]
14. Refining stability and dissolution rate of amorphous drug formulations.
Grohganz H; Priemel PA; Löbmann K; Nielsen LH; Laitinen R; Mullertz A; Van den Mooter G; Rades T
Expert Opin Drug Deliv; 2014 Jun; 11(6):977-89. PubMed ID: 24754747
[TBL] [Abstract][Full Text] [Related]
15. Producing Amorphous Solid Dispersions via Co-Precipitation and Spray Drying: Impact to Physicochemical and Biopharmaceutical Properties.
Mann AKP; Schenck L; Koynov A; Rumondor ACF; Jin X; Marota M; Dalton C
J Pharm Sci; 2018 Jan; 107(1):183-191. PubMed ID: 28711592
[TBL] [Abstract][Full Text] [Related]
16. Recent Advances in Understanding the Micro- and Nanoscale Phenomena of Amorphous Solid Dispersions.
Ricarte RG; Van Zee NJ; Li Z; Johnson LM; Lodge TP; Hillmyer MA
Mol Pharm; 2019 Oct; 16(10):4089-4103. PubMed ID: 31487183
[TBL] [Abstract][Full Text] [Related]
17. Effects of the Preparation Process on the Properties of Amorphous Solid Dispersions.
Huang S; Williams RO
AAPS PharmSciTech; 2018 Jul; 19(5):1971-1984. PubMed ID: 28924730
[TBL] [Abstract][Full Text] [Related]
18. Haste Makes Waste: The Interplay Between Dissolution and Precipitation of Supersaturating Formulations.
Sun DD; Lee PI
AAPS J; 2015 Nov; 17(6):1317-26. PubMed ID: 26338234
[TBL] [Abstract][Full Text] [Related]
19. Use of Polyvinyl Alcohol as a Solubility Enhancing Polymer for Poorly Water-Soluble Drug Delivery (Part 2).
Brough C; Miller DA; Ellenberger D; Lubda D; Williams RO
AAPS PharmSciTech; 2016 Feb; 17(1):180-90. PubMed ID: 26863889
[TBL] [Abstract][Full Text] [Related]
20. Delivery of poorly soluble compounds by amorphous solid dispersions.
Lee TW; Boersen NA; Hui HW; Chow SF; Wan KY; Chow AH
Curr Pharm Des; 2014; 20(3):303-24. PubMed ID: 23651395
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]